Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery

Circulation

Volumn 90, Issue 2, 1994, Pages 921-927

  Rocha, Eduardo ^a   Hidalgo, Francisco ^a   Llorens, Rafael ^a   Melero, José M ^a   Arroyo, José L ^a   Páramo, José A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

aprotinin; cardiopulmonary bypass; desmopressin acetate; fibrinolysis

Indexed keywords

APROTININ; DESMOPRESSIN ACETATE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BYPASS SURGERY; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS;

EID: 0028133005     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.90.2.921     Document Type: Article

References (58)

1. Bachman F, McKenna R, Cole ER, Najafi H. The hemostatic mechanism after open-heart surgery, I: studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. J Thorac Cardiovasc Surg. 1975;70:76-85.
2. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990;76:1680-1697.
3. Bick RL. Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits. Semin Thromb Hemost. 1985;11:249-280.
4. Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost. 1985;11: 281-292.
5. Kucuk O, Kwaan HC, Frederickson J, Wade L, Green D. Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation. Am J Hematol. 1986;23:223-229.
6. Gram J, Janetzko T, Jespersen J, Bruhm HD. Enhanced fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of postsurgical bleeding. Thromb Haemost. 1990;63:241-245.
7. Harker LA. Bleeding after cardiopulmonary bypass. N Engl J Med. 1986;314:1445-1448.
8. George JN, Pickett EB, Saucerman S, McEver R, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins: studies on resting and activated platelets and platelet membrane microparticles in normal subjects and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 1986;78:340-348.
9. Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, Birjiniuk V, Ouimet H, Pasche B, Nelson MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD. The platelet function defect of cardiopulmonary bypass. Blood. 1993;82:107-117.
10. Mannucci PM. Desmopressin for treatment of disorders of hemostasis. Prog Hemost Thromb. 1986;8:19-45.
11. Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983;308:8-12.
12. Kobrinsky NL, Israels ED, Gerrard JM, Cheang MS, Watson CM, Bishop AJ, Schroeder ML. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders. Lancet. 1984;1:1145-1148.
13. Mannucci PM, Vicente V, Vianello L, Cattaneo M, Alberca I, Coccato MP, Faioni M, Mari D. Controlled trial of desmopressin (DDAVP) in liver cirrhosis and other conditions associated with prolonged bleeding time. Blood. 1986;67:1148-1153.
14. Kobrinsky NL, Letts RM, Patel LR, Israels ED, Monson R, Schwetz N, Cheang MS. 1-Desamino-8-D arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. Ann Intern Med. 1987;107: 446-450.
15. Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RL, Robertson L, Donovan A, Gaffney T, Bertele V, Smith JTM, Chute LE. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double-blind randomized trial. N Engl J Med. 1986;314:1402-1406.
16. Rocha E, Llorens R, Páramo JA, Arcas R, Cuesta B, Martín Trenor A. Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation. 1988; 77:1319-1323.
17. Rocha E, Páramo JA, Llorens R, Hidalgo F. Desmopressin in cardiac surgery with extracorporeal circulation. In: Mariani G, Mannucci PM, Cattaneo M, eds. Desmopressin in Bleeding Disorders. New York, NY: Plenum Press; 1993:191-202.
18. Van Oeveren W, Jansen NJG, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CR. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg. 1987;44:640-645.
19. Blauhut B, Gross C, Necek S, Doran JE, Spath P, Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991:101:958-967.
20. Harker LA, Malpass TW, Branson HE, Hessel EA, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. Blood. 1980;56:824-834.
21. O'Brian JR, Green PJ, Salmon G, Weir P, Colin Jones D, Arnold M, Chopra S. Desmopressin and myocardial infarction. Lancet. 1989;1:664-665.
22. Bohrer H, Fleischer F, Lang J, Vahl C. Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin. J Cardiothorac Anesth. 1990;4:222-225.
23. Páramo JA, Alfaro MJ, Rocha E. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fastacting inhibitor: relationship to deep vein thrombosis and influence of prophylaxis. Thromb Haemost. 1985;54:713-716.
24. Nieuwenhuizen W. The use of monoclonal antibodies in demonstrating different fibrinogen derivatives. In: Muller-Berghaus G, Scheefers-Borchel U, Selmayr E, Henschen A, eds. Fibrinogen and Its Derivatives. Biochemistry, Physiology and Pathophysiology. Amsterdam, the Netherlands: Excerpta Medica; 1986:245-256.
25. Czer L, Bateman T, Gray R, Raymond M, Chaux A, Mattlof J, Stewart M. Prospective trial of DDAVP in treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass. Circulation. 1985;72(suppl III):III-130. Abstract.
26. Weinstein M, Ware JA, Troll J, Salzman E. Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood. 1988;71:1648-1655.
27. Hackmann T, Gascoyne RN, Naiman SC, Growe GH, Burchill LD, Jamieson E, Sheps S, Schechter MT, Townsend GE. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med. 1989; 321:1437-1443.
28. Andersson TLG, Solem JO, Tengborn L, Vinge E. Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation. 1990;81:872-878.
29. Seear MD, Wadsworth LD, Rogers PC, Sheps S, Ashmore PG. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovasc Surg. 1989;98:217-219.
30. Lazenby WD, Russo I, Zadeh BJ, Zelano JA, Ko W, Lynch CC, Isom OW, Kneger KH. Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis. Circulation. 1990;82(suppl IV):IV-413-IV-419.
31. Hedderich GS, Petsikas DJ, Cooper BA, Leznoff M, Guerraty AJ, Poirier NL, Symes JF, Morin JE. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Can J Surg. 1990;33:33-36.
32. LoCicero J, Massad M, Matano J. Effect of desmopressin on hemorrhage without identifiable cause in coronary bypass patients. Ann Surg. 1991;57:165. Abstract.
33. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med. 1985;103:228-239.
34. Czer L, Capon SM. Clinical experience in disorders of haemostasis. Drug Invest. 1990;2(suppl 5):32-44.
35. Chard RB, Kamm CA, Nunn GR, Johnson DC, Meldrum-Hanna W. Use of desmopressin in the management of aspirin-related and intractible haemorrhage after cardiopulmonary bypass. Aust N Z J Surg. 1990;60:125-128.
36. Rocha E, Llorens R, Páramo JA. Desmopressin and surgical hemostasis, N Engl J Med. 1990;322:1085. Letter.
37. Tice DA, Reed GE, Clauss RH, Worth MH. Hemorrhage due to fibrinolysis occurring with open heart operations. J Thorac Cardiovasc Surg. 1963;46:673-679.
38. Tice DA, Worth MH, Clauss RH, Reed GE. The inhibition of Trasylol of fibrinolytic activity associated with cardiovascular operations. Surg Gynecol Obstet. 1964;119:71-74.
39. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987;2:1289-1291.
40. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989;97: 364-372.
41. Havel M, Teufelsbauer H, Knöbl P, Dalmatiner R, Jaksh P, Zwölfer W, Müller M, Vukovich T. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. J Thorac Cardiovasc Surg. 1991;101:968-972.
42. Mohr R, Goor DA, Lusky A, Lavee J. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction: a scanning electron microscope study. Circulation. 1992;86(suppl II):II-405-II-409.
43. Czer LSC, Bateman TM, Cray RJ, Raymond M, Stewart ME, Lee S, Goldfinger D, Chaux A, Matloff JM. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin. J Am Coll Cardiol. 1987;9:1139-1147.
44. Mannucci PM, Lusher J. Desmopressin and thrombosis. Lancet. 1989;2:675-676.
45. Mannucci PM, Carlsson S, Harris AS. Desmopressin, surgery and thrombosis. Thromb Haemost. 1994;71:154-155.
46. Cosgrove DM, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LAR, Stewart RW, McCarthy PM, Loop FD. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg. 1992;54:1031-1038.
47. Gerbash PH, Lämmle B, Schüpbach P, Mühlemann W, Althaus U. Major coagulation disorders when using aprotinin: observations on a case. Thorac Cardiovasc Surg. 1991;39:196-198.
48. Kucuk O, Kwaan HC, Frederickson J, Wode L, Green D. Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation. Am J Hematol. 1986;23:223-229.
49. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Caprini JA. Decreased platelet number and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 1988;29:62-67.
50. Páramo JA, Rifón J, Llorens R, Casares J, Paloma MJ, Rocha E. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery. Haemostasis. 1991;21:58-64.
51. Teufelsbauer H, Proidl S, Havel M, Vukovich T. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost. 1992;68:250-252.
52. MacGregor IR, Roberts EM, Prowse CB, Broomhead AF, Ozolins M. Fibrinolytic and hemostatic response to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy individuals. Thromb Haemost. 1988;59: 34-39.
53. Van Oeveren W, Harder MP, Roozendaal KJ, Eigsman MD, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990; 99:788-797.
54. Royston D. The serine antiprotease aprotinin (Trasylol™): a novel approach to reducing postoperative bleeding. Blood Coagul Fibrinolysis. 1990;1:55-69.
55. Orchard MA, Goodchild CS, Prentice CRM, Davies JA, Benoit SE, Creighton-Kemsford LJ, Gaffney PJ, Michelson HD. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets. Br J Haematol. 1993;85:533-541.
56. Vander Salm TJ, Ansell JE, Okike ON, Marsicano TH, Lew R, Stephenson WP, Rooney K. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double blind randomized study. J Thorac Cardiovasc Surg. 1988;95:538-540.
57. Horrow JC, Hlavacek J, Strong MD, Collier W, Brodsky J, Goldman SM, Goel IP. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg. 1990; 99:70-74.
58. Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation. 1991;84:2063-2070.